Dominant negative selection of vaccinia virus using a thymidine kinase/thymidylate kinase fusion gene and the prodrug azidothymidine
- 1. Baxter BioScience/Vaccines, Biomedical Research Center, Uferstrasse 15, A-2304 Orth/Donau (Austria)
Description
The Escherichia coli thymidine kinase/thymidylate kinase (tk/tmk) fusion gene encodes an enzyme that efficiently converts the prodrug 3'-azido-2',3'-dideoxythymidine (AZT) into its toxic triphosphate derivative, a substance which stops DNA chain elongation. Integration of this marker gene into vaccinia virus that normally is not inhibited by AZT allowed the establishment of a powerful selection procedure for recombinant viruses. In contrast to the conventional vaccinia thymidine kinase (tk) selection that is performed in tk-negative cell lines, AZT selection can be performed in normal (tk-positive) cell lines. The technique is especially useful for the generation of replication-deficient vaccinia viruses and may also be used for gene knock-out studies of essential vaccinia genes
Additional details
Identifiers
- DOI
- 10.1016/j.virol.2005.04.009;
- PII
- S0042-6822(05)00215-1;
Publishing Information
- Journal Title
- Virology
- Journal Volume
- 337
- Journal Issue
- 2
- Journal Page Range
- p. 235-241
- ISSN
- 0042-6822
- CODEN
- VIRLAX
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 37037483
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- DNA; ENZYMES; ESCHERICHIA COLI; GENES; THYMIDINE; VACCINIA VIRUS
- Descriptors DEC
- AZINES; BACTERIA; HETEROCYCLIC COMPOUNDS; MICROORGANISMS; NUCLEIC ACIDS; NUCLEOSIDES; NUCLEOTIDES; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; PARASITES; PROTEINS; PYRIMIDINES; RIBOSIDES; VIRUSES
Optional Information
- Copyright
- Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.